Registration statement for securities of certain foreign private issuers

Consolidated Statements of Cash Flows

v3.21.2
Consolidated Statements of Cash Flows - USD ($)
 1 Months Ended 12 Months Ended
Dec. 31, 2019
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:          
Net loss     $ (81,511,000) $ (67,301,000) $ (56,400,000)
Adjustments required to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization     2,661,000 1,674,000 660,000
Share-based compensation     3,196,000 2,171,000 1,377,000
Capital loss (gain)     (6,000) 0 325,000
Issuance of Preferred C-1 Shares to a customer     14,800,000 0 0
Foreign exchange (gain) loss     (572,000) (729,000) 612,000
Decrease (increase) in prepaid expenses and other assets     (1,296,000) 1,231,000 (2,557,000)
Increase in trade receivable     (1,485,000) (1,060,000) (59,000)
Increase in inventories     (823,000) (200,000) (1,141,000)
Increase (decrease) in trade payables     606,000 (2,255,000) 7,412,000
Increase (decrease) in accrued expenses and other liabilities     (820,000) (5,566,000) 7,426,000
Increase in employees and payroll accruals     2,111,000 223,000 1,618,000
Increase in advances from customers and deferred revenues     1,198,000 2,587,000 1,348,000
Changes in operating assets and liabilities:          
Net cash used in operating activities     (61,941,000) (69,225,000) (39,379,000)
Cash flows from investing activities:          
Purchase of property and equipment     (5,120,000) (5,850,000) (6,853,000)
Proceeds from sales of property and equipment     47,000 0 7,000
Proceeds from (investment in) bank deposits, net     34,720,000 (34,720,000) 47,002,000
Increase in restricted deposits     (56,000) 0 0
Net cash provided by (used in) investing activities     29,591,000 (40,570,000) 40,156,000
Cash flows from financing activities:          
Proceeds from Issuance of convertible preferred shares, net of issuance expenses     8,934,000 161,233,000 0
Proceeds from exercise of options     284,000 73,000 10,000
Proceeds from loan     0 2,020,000 584,000
Repayment of loan     (277,000) (204,000) 0
Net cash provided by financing activities     8,941,000 163,122,000 594,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash     748,000 900,000 (612,000)
Increase (decrease) in cash, cash equivalents and restricted cash     (22,661,000) 54,227,000 759,000
Cash, cash equivalents and restricted cash at beginning of the year     73,427,000 19,200,000 18,441,000
Cash, cash equivalents and restricted cash at end of the year $ 73,427,000 $ 73,427,000 50,766,000 73,427,000 19,200,000
Cash – Beginning     72,792,000 18,555,000  
Cash – Ending 72,792,000 72,792,000 49,950,000 72,792,000 18,555,000
Cash received during the year for:          
Interest     553,000 1,279,000 493,000
Cash paid during the year for:          
Interest     89,000 94,000 29,000
Income taxes     85,000 10,000 28,000
Non-cash transactions:          
Investment in non-marketable equity securities in consideration for property and equipment     64,000 98,000 0
Reclassification from property and equipment. net to inventories     512,000 0 0
Cash, cash equivalents and restricted cash at end of the year          
Cash and cash equivalents 72,792,000 72,792,000 49,950,000 72,792,000 18,555,000
Short-term restricted deposits 8,000 8,000 8,000 8,000 8,000
Restricted deposits 627,000 627,000 808,000 627,000 637,000
Cash, cash equivalents and restricted cash at end of the year 73,427,000 73,427,000 50,766,000 73,427,000 $ 19,200,000
Collective Growth Corp [Member]          
Cash flows from operating activities:          
Net loss (348) (348) (29,854,803)    
Adjustments required to reconcile net loss to net cash used in operating activities:          
Interest earned on marketable securities held in Trust Account     (94,642)    
Unrealized gain on marketable securities held in Trust Account     (5,441)    
Change in fair value of warrant liability     26,454,375    
Compensation expense     1,665,188    
Deferred consulting fee payable     72,000    
Changes in operating assets and liabilities:          
Prepaid expenses     (61,651)    
Accrued expenses     371,244    
Transaction costs associated with Initial Public Offering     700,705    
Net cash used in operating activities   (348) (753,025)    
Cash flows from investing activities:          
Investment of cash into Trust Account     (150,000,000)    
Net cash provided by (used in) investing activities     (150,000,000)    
Cash flows from financing activities:          
Proceeds from sale of Units, net of underwriting discounts paid     147,000,000    
Proceeds from sale of Private Placement Units     2,625,000    
Proceeds from sale of Private Placement Warrants     1,875,000    
Proceeds from promissory notes – related party   7,848 104,058    
Repayment of promissory notes – related party     (111,906)    
Payment of offering costs   (7,500) (454,797)    
Net cash provided by financing activities   348 151,037,355    
Net Change in Cash     284,330    
Cash – Beginning     0    
Cash – Ending 0 0 284,330 0  
Cash, cash equivalents and restricted cash at end of the year          
Cash and cash equivalents $ 0 0 284,330 $ 0  
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]          
Initial classification of Class A common stock subject to redemption     131,280,140    
Change in value of Class A common stock subject to possible redemption     (33,503,140)    
Deferred underwriting fee payable     $ 5,250,000    
Offering costs paid by Sponsor in exchange for issuance of Class B common stock   $ 25,000